These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 10079873)

  • 21. [The pharmacodynamics and pharmacokinetics of fluoroquinolones in the evaluation of antibacterial therapy regimens].
    Smirnova LB; Sokolova VI
    Antibiot Khimioter; 2000; 45(7):14-6. PubMed ID: 10987102
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selecting anti-infective agents for the treatment of bone infections.
    Venugopalan V; Smith KM; Young MH
    Orthopedics; 2007 Sep; 30(9):713-7. PubMed ID: 17899911
    [No Abstract]   [Full Text] [Related]  

  • 23. [Effectiveness of pefloxacin in brucellosis].
    Kurmanova KB; Kkhamfyang S; Iudin SM
    Antibiot Khimioter; 1995 Jul; 40(7):39-42. PubMed ID: 8645059
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical and laboratory investigation of pefloxacin used prophylactically in operations on the liver].
    Khlebnikov EP; Vishnevskiĭ VA; Kubyshkin VA; Terekhova RP
    Antibiot Khimioter; 2009; 54(3-4):32-7. PubMed ID: 19711848
    [No Abstract]   [Full Text] [Related]  

  • 25. Pefloxacin clinical pharmacokinetics.
    Bressolle F; Gonçalves F; Gouby A; Galtier M
    Clin Pharmacokinet; 1994 Dec; 27(6):418-46. PubMed ID: 7882634
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinico-pharmacologic aspects of the use of ofloxacin].
    Kukes VG; Belitskaia RA; Dubova MN; Krasavina MIu; Posrednikova TA
    Antibiot Khimioter; 1996; 41(9):39-42. PubMed ID: 9005783
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serious, life-threatening infections: results with pefloxacin.
    Gargalianos P; Lelekis M; Lanaras L; Karakatsani E; Tsouroulas P; Kosmidis J
    J Chemother; 1989 Jul; 1(4 Suppl):672-3. PubMed ID: 16312586
    [No Abstract]   [Full Text] [Related]  

  • 28. Stereoselectivity of ofloxacin intestinal transport in the rat.
    Rabbaa L; Dautrey S; Colas-Linhart N; Carbon C; Farinotti R
    Drugs; 1995; 49 Suppl 2():333-4. PubMed ID: 8549352
    [No Abstract]   [Full Text] [Related]  

  • 29. Pharmacokinetics of pefloxacin in human prostatic tissue.
    Salpigides G; Pangalis A; Kouvelas D; Paradelis AG
    J Chemother; 1995 Nov; 7 Suppl 4():105-6. PubMed ID: 8904124
    [No Abstract]   [Full Text] [Related]  

  • 30. [Pefloxacin (Abactal): role in treatment of severe surgical infections].
    Gel'fand EB
    Antibiot Khimioter; 2000; 45(8):48. PubMed ID: 10989725
    [No Abstract]   [Full Text] [Related]  

  • 31. [Pefloxacin in the treatment of severe infections in intensive care].
    Gritti G; Capuzzo M; Verri M; Nepoti ML; Nardini A
    Minerva Anestesiol; 1988 Sep; 54(9):367-72. PubMed ID: 3249624
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of subinhibitory concentrations of pefloxacin in infection in mice due to susceptible or resistant strains.
    Carsenti-Etesse H; Bensoussan M; Bensoussan F; Durant J; Pradier C; Mondain V; Bernard E; Dellamonica P
    Drugs; 1995; 49 Suppl 2():276-8. PubMed ID: 8549331
    [No Abstract]   [Full Text] [Related]  

  • 33. [Therapeutic contribution of the new quinolones].
    Wolff M
    Rev Prat; 1987 Apr; 37(21):1209-14. PubMed ID: 3474759
    [No Abstract]   [Full Text] [Related]  

  • 34. Pefloxacin versus cefuroxime axetil for single-dose therapy of acute uncomplicated lower urinary tract infections in women.
    Krcmery S; Hromec J; Gulla D
    J Chemother; 1995 Nov; 7 Suppl 4():168-9. PubMed ID: 8904145
    [No Abstract]   [Full Text] [Related]  

  • 35. Pefloxacin in the treatment of gram-negative infections in patients with hematologic diseases.
    Micozzi A; Martino P; Raccah R; Girmenia C; Gentile G; Santilli S; Monarca B
    Haematologica; 1989; 74(6):583-5. PubMed ID: 2628241
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quinolone antimicrobial agents in acute exacerbations of chronic bronchitis.
    Maesen FP; Davies BI; Teengs JP; Baur C
    Eur J Respir Dis Suppl; 1986; 146():585-90. PubMed ID: 3465584
    [No Abstract]   [Full Text] [Related]  

  • 37. [Effectiveness of pefloxacin in the surgical clinic].
    Iakovlev VP; Blatun LA; Khlebnikov EP; Elagina LV; Puchkova LS
    Antibiot Khimioter; 1995 Aug; 40(8):43-5. PubMed ID: 8713438
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rifaximin: a nonabsorbable rifamycin antibiotic for use in nonsystemic gastrointestinal infections.
    Gerard L; Garey KW; DuPont HL
    Expert Rev Anti Infect Ther; 2005 Apr; 3(2):201-11. PubMed ID: 15918778
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pefloxacin in the treatment of 24 suppurative infections.
    Desplaces N; Mamoudy P; Leonard P; Houdart R; Rouchy J; Kitzis M; Gutmann L
    Chemioterapia; 1987 Jun; 6(2 Suppl):394-5. PubMed ID: 3509457
    [No Abstract]   [Full Text] [Related]  

  • 40. [Pefloxacin in the treatment of the bone and joint infections].
    Maiello A; Dassio G; Calvo MM; Gramoni A
    Minerva Med; 1999; 90(1-2):33-7. PubMed ID: 10388461
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.